INSIGHTS ON CLINICAL TRIAL DESIGN

• Understanding Decentralized Clinical Trials: FDA vs. EMA Fundamentals

  Designing a global decentralized clinical trial requires understanding the differing FDA and EMA approaches to trial models and informed consent.

• Simplifying ePRO Data Collection

  The Bring Your Own Device (BYOD) model, supported by Trialkit, is an innovative approach in clinical trials that allows participants to use personal smartphones or tablets for data collection.

• IRT: A New Approach To Meeting The Needs Of Early Phase Trials

  As early phase clinical trials become more sophisticated, sponsors are now leveraging flexible IRT solutions to replace error-prone manual processes and gain greater control and efficiency.

• The Benefit Of Applying Corporate Meetings Management Best Practices

  Discover how a structured, scalable approach to patient support can streamline trial operations, improve retention, and elevate the clinical experience for everyone involved.

• Obesity Clinical Research: Patient Recruitment Challenges

  1/15/2026

  Obesity trials face enrollment hurdles. Learn how data-driven insights, patient-first strategies, and decentralized models can break barriers, ease burden, and accelerate timelines.

• Investigator Perspectives On What Matters In Obesity And GLP-1 Studies

  7/22/2026

  Retention, body composition, maintenance therapy, amylin combinations, and behavioral support are reshaping obesity trials. Learn how sponsors can reduce dropout risk and strengthen clinical data.

• Addressing Trial Design Hurdles Across Alzheimer's Disease Stages

  12/10/2025

  Explore how endpoint selection, rater training, and the strategic implementation of eCOA can help address the unique scientific, operational, and human considerations at each stage of AD.

• Multi-Regional Clinical Trials: The Latest Guidance From FDA

  3/12/2025

  Conducting multi-regional clinical trials (MRCTs) is essential for accelerating oncology drug development and ensuring broader patient access. However, differences across regions can impact findings.

• Understanding The FDA's Push For More Representation In Clinical Trials

  1/28/2025

  Take action to improve diversity in clinical trials by addressing underrepresentation and ensuring equitable access to medical interventions, as emphasized by the FDA’s new 2025 guidance.